The incorporation of CRISPR/Cas9 into clinical settings has promising applications for the future treatment of genetic disorders, human immunodeficiency virus (HIV) infection, and various ...

However, CRISPR Therapeutics is not without its challenges. It faces intense competition from other gene-editing companies, both within and outside the CRISPR/Cas9 platform.

But until now, no one has used CRISPR-Cas9 on spiders. Researchers at the University of Bayreuth have recently successfully bred the world’s first CRISPR-Cas9-modified spider to produce red ...

CRISPR-Cas9 has been of particular interest in the field of liver research. For example, hepatitis B virus (HBV)-associated diseases are primarily caused by the persistence of HBV covalently ...

Learn more about CRISPR in this summary article. Avoiding CRISPR Off-Target Effects by Tweaking the Timing of Edits Double-strand DNA breaks not only open the door to unwanted, off-target editing, but ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

With the CRISPR/Cas9 snip, BCL11A is shut off, and HbF production can resume. For patients being treated, this process involves first harvesting their bone marrow stem cells, which then get CRISPR ...

In 2016, scientists conducted the first CRISPR-related clinical trial involving human recipients and demonstrated the possibility and safety of its clinical application. 1 In this clinical trial, ...